HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
SAN DIEGO, Dec. 3, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, announced the addition of three experienced executives to the management team. John P. Longenecker, Ph.D. was appointed to serve as President, CEO and Director, Richard Ghalie, MD as Chief Medical ...
Read more on redOrbit
Orignal From: HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
Post a Comment